FG
GMED icon

Foresight Group’s Globus Medical GMED Stock Holding History

Foresight Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.8M Sell
254,030
-39,873
-14% -$3.39M 3.56% 9
2026
Q1 		$25.3M Sell
293,903
-50,704
-15% -$4.55M 4.47% 3
2025
Q4 		$30.3M Sell
344,607
-76,934
-18% -$5.84M 4.56% 3
2025
Q3 		$24.1M Buy
421,541
+259,870
+161% +$15M 3.6% 12
2025
Q2 		$9.54M Sell
161,671
-2,192
-1% -$142K 1.35% 33
2025
Q1 		$12M Buy
+163,863
New +$13.5M 1.69% 24

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Foresight Group's GMED Position: Q2 2026 in Review

Foresight Group reduced its Globus Medical (GMED) stake by 14% in Q2 2026, selling an estimated $3.39M and leaving 254,030 shares worth $19.8M. The position accounts for 3.56% of the portfolio, ranked #9.

Foresight Group first reported a position in GMED in Q1 2025 and has held it in 6 quarters since. The position peaked at $30.3M in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Foresight Group held 254,030 shares of Globus Medical worth $19.8M as of Q2 2026.
  • Foresight Group sold 39,873 Globus Medical shares in Q2 2026, an estimated $3.39M.
  • Globus Medical made up 3.56% of Foresight Group's portfolio in Q2 2026, its #9 holding.
  • Foresight Group first reported a position in Globus Medical in Q1 2025 and has held it in 6 quarters since.
  • Foresight Group's Globus Medical position peaked at $30.3M in Q4 2025.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Foresight Group's 13F filing for Q2 2026, filed 27 Jul 2026.